中医药传承发展是国家战略的重要组成部分。在这一战略下，国家也推出了一系列政策。国务院印发的《中医药发展战略规划纲要（2016-2030年）》，明确中医药治未病的主导作用和重大疾病的协同作用，对中医药有了明确精准的定位；《中医药发展“十三五”规划》为中医药发展指明了方向，也提供了保障；《中医药法》则提到中医药纳入医保体系。这些文件的发布，为包括中药、中药饮片在内的大健康产业发展，提供强有力的法律保障和政策支持。
The inheritance and development of traditional Chinese medicine is an important part of the national strategy. Under this strategy, the country has also launched a series of policies. The Outline of Strategic Planning for the Development of Traditional Chinese Medicine (2016-2030), issued by the State Council, clarifies the leading role of traditional Chinese medicine in the prevention of diseases and the synergistic effect of major diseases, and has a clear and precise positioning of traditional Chinese medicine; the Thirteenth Five-Year Plan for the Development of Traditional Chinese Medicine points out the direction for the development of traditional Chinese medicine and also provides guarantee; and the Chinese Medicine The Medical Law refers to the incorporation of traditional Chinese medicine into the medical insurance system. The issuance of these documents will provide strong legal protection and policy support for the development of large and healthy industries, including traditional Chinese medicine and Chinese herbal decoction pieces.
在业内人士看来，中药饮片纳入国家基本药物、不占药占比、不实施“零加成”等政策，使其处于中医药政策发展的红利风口。有数据显示，2017年中药饮片市场规模达256亿元，同比增长10.5%，预计2018年仍然维持较高的增长速度，销售规模将达到277亿元。三七、西洋参、枸杞子、黄芪、川贝、冬虫夏草、石斛、红参、菊花、大枣，是零售市场规模前十的品种，预计三七、西洋参2018年将维持高于品类均值的增长水平。
In the view of the industry, Chinese herbal decoction pieces are included in the national essential drugs, do not account for the proportion of medicines, do not implement the "zero-plus" policy, so that they are in the dividend wind of the development of Chinese medicine policy. According to the data, the market size of Chinese Herbal Pieces reached 25.6 billion yuan in 2017, an increase of 10.5% over the same period last year. It is expected that the market will maintain a high growth rate in 2018, and the sales scale will reach 27.7 billion yuan. Panax notoginseng, American ginseng, Lycium barbarum, Astragalus membranaceus, Chuanbei, Cordyceps sinensis, Dendrobium, Red ginseng, Chrysanthemum and Date are the top ten varieties in the retail market. It is expected that Panax notoginseng and American ginseng will maintain a growth level higher than the average of categories in 2018.